National Comprehensive Cancer Network
Supporter and Exhibitor Opportunities
NCCN Guidelines and Compendium Updated
Flash Update Sent July 17, 2012
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer Screening and Diagnosis. These NCCN Guidelines® are currently available as Version 1.2012.
- The panel defined the starting age for screening recommendations for the following group of individuals:
- For women who have a lifetime risk >20% as defined by models that are largely dependent on family history (eg, Claus, BRCAPRO, BOADICEA, Tyrer-Cuzick risk models), the panel recommends annual mammogram and clinical breast exam every 6-12 months, beginning at age 30 years, as well as consideration of annual breast MRI beginning at 30 years.
- For women younger than 25 years who have received prior thoracic irradiation, the panel recommends encouraging annual clinical breast exam starting 8-10 years after the radiation therapy.
- For individuals with pedigree suggestive of or with known genetic predisposition, the panel added screening recommendations for Hereditary Breast and Ovarian Cancer (HBOC) and added a new footnote stating, "There is variation in recommendations for initiation of screening for different genetic syndromes. See NCCN Guidelines® for Genetic/Familial High Risk Assessment."
- The Discussion section has been updated to reflect the changes in the algorithm.
For the complete updated version of these and all NCCN Guidelines, visit NCCN.org.